首页 | 本学科首页   官方微博 | 高级检索  
     


Management of Crohn's disease and ulcerative colitis
Affiliation:1. Institut des maladies de l''appareil digestif, CHU de Nantes, Nantes, France;2. Service d''hépatogastroentérologie, Hôpital de La Cavale-Blanche, CHU de Brest, Université de Bretagne occidentale, Brest, France;3. Service d''anatomie pathologique, CHU d''Amiens, Amiens, France;4. Service d''anatomie et cytologie pathologiques, Hôpital Saint-Antoine, AP-HP, Faculté de médecine Pierre et Marie Curie, Paris, France;1. Centre for Asthma, Allergy and Respiratory Research, The Lung Institute of Western Australia, The University of Western Australia, Nedlands, Australia;2. School of Medicine and Pharmacology, The University of Western Australia, Nedlands, Australia;3. School of Pathology and Laboratory Medicine, The University of Western Australia, Nedlands, Australia;4. Department of Respiratory and Sleep Medicine, Royal Perth Hospital, Perth, Australia;1. Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong;2. Ethnic Drug Screening & Pharmacology Center, Key Laboratory of Chemistry in Ethnic Medicinal Resources, State Ethnic Affairs Commission & Ministry of Education, Yunnan Minzu University, Kunming 650500, China;3. Institute of New Drug Research and Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine, Jinan University College of Pharmacy, Guangzhou 510632, China;4. School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong;5. Institute of Chinese Medical Sciences, University of Macau, Macau, China;6. Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong;7. Department of Physiology, The University of Hong Kong, Hong Kong
Abstract:Crohn's disease and ulcerative colitis (UC) are complex, contrasting disease processes that require multidisciplinary team management. The treatment modalities in inflammatory bowel disease are varied and the indications and threshold for surgery quite different in patients with UC compared with Crohn's disease. We discuss the panoply of surgical techniques available to the surgeon and IBD-patient whilst highlighting the potential sequelae, complimentary medical therapies, nutritional considerations and innovative techniques for reconstruction of the gastrointestinal tract.
Keywords:Crohn's disease  inflammatory bowel disease  surgical management  ulcerative colitis
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号